Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
7R29NS033230-05
Application #
2643649
Study Section
Physiology Study Section (PHY)
Program Officer
Baughman, Robert W
Project Start
1994-08-01
Project End
1999-07-31
Budget Start
1998-03-23
Budget End
1998-07-31
Support Year
5
Fiscal Year
1997
Total Cost
Indirect Cost

  Institution

Name
Amur Pharmaceuticals, Inc.
Department
Type
DUNS #
City
Belmont
State
CA
Country
United States
Zip Code
94002

  Publications

Nichols, M R; Morimoto, B H (2000) Differential inhibition of multiple cAMP phosphodiesterase isozymes by isoflavones and tyrphostins. Mol Pharmacol 57:738-45
Hurst, W J; Moroz, L L; Gillette, M U et al. (1999) Nitric oxide synthase imunolabeling in the molluscan CNS and peripheral tissues. Biochem Biophys Res Commun 262:545-8
Nichols, M R; Morimoto, B H (1999) Tyrosine kinase-independent inhibition of cyclic-AMP phosphodiesterase by genistein and tyrphostin 51. Arch Biochem Biophys 366:224-30
Stringfield, T M; Morimoto, B H (1997) Modulation of cyclic AMP levels in a clonal neural cell line by inhibitors of tyrosine phosphorylation. Biochem Pharmacol 53:1271-8